
|Articles|June 15, 2015
Frustration Over US–EU Trade Agreement Delay
June 15, 2015.
Advertisement
The European Parliament decision last week to postpone a vote on a free trade deal with the US has caused frustration among the business community. The delaying of the vote on the Transatlantic Trade and Investment Partnership (TTIP) resolution was attributed to a large number of amendments, but TTIP has become increasingly controversial in Europe, with much criticism from left wing and campaign groups concerning its potential impact on labor rights, environmental standards and public services.
G7 leaders have urged that agreement on the trade deal should be in place by the end of this year.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
3
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
4
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
5




